Table of Contents Table of Contents
Previous Page  72 / 120 Next Page
Information
Show Menu
Previous Page 72 / 120 Next Page
Page Background

/72/

Israel’s Life

Sciences Industry:

2016 Assessment

Israel’s life science industry continues to thrive and has experienced rapid growth in

recent years. Following a decade of significant growth, the Israeli life sciences industry

plays a pivotal role in the world healthcare market, underpinned by its innovation and

excellence in academic research, government support and increasing funding options.

These factors are leading to ever more success and record investments, especially

from China. There are more companies involved in advanced stages of clinical trials

and an ever larger number of successful M&A transactions and IPOs of Israeli life

sciences companies, particularly on the NASDAQ.

Recent high profile transactions include the sale of cCAM Biotherapeutics to Merck

(for up to US$605 million), the sale of MIS Implants to Dentsply Sirona (for US$375

million) and the sale of HeartWare to Valtech for a reported US$929 million – almost

US$2 billion from three deals.

In addition, in one of the most significant China-Israel transactions to date in the

life science area, Oramed Pharmaceuticals concluded a US$50 million licensing and

investment deal with China’s Hefei Tianhui Incubator of Technologies Co. for rights

to Oramed’s oral insulin capsule technology in China. These transactions follow

other major life science transactions attracting global attention such as the 2014

acquisition by Covidien (now Medtronic) of Given Imaging, developer of the world-

famous “PillCam”, for US$860 million. These transactions are just the tip of the

iceberg.

In this article, we explore the sources of Israel’s vibrant life sciences industry and the

financing opportunities available in this area.

Sources of Life Science Innovation

Among the sources of life science innovation in Israel are first rate academic and

medical institutions, enhanced government support, and the active presence of

global life science companies in Israel.

Israel is blessed with a large number of world class academic and medical

institutions within a relatively small geographic area, giving rise to an

environment of cross-fertilization of disciplines that led to innovation in

medical technology.